PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 257 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,505 | -43.6% | 300 | -10.2% | 0.00% | – |
Q2 2023 | $4,442 | +27.9% | 334 | +11.3% | 0.00% | – |
Q1 2023 | $3,474 | -1.7% | 300 | -30.6% | 0.00% | – |
Q4 2022 | $3,534 | +76.7% | 432 | +24.9% | 0.00% | – |
Q3 2022 | $2,000 | – | 346 | +652.2% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 46 | -89.5% | 0.00% | -100.0% |
Q1 2022 | $4,000 | -20.0% | 437 | +85.2% | 0.00% | 0.0% |
Q4 2021 | $5,000 | -37.5% | 236 | -25.8% | 0.00% | -50.0% |
Q3 2021 | $8,000 | -33.3% | 318 | -4.8% | 0.00% | -33.3% |
Q2 2021 | $12,000 | +9.1% | 334 | 0.0% | 0.00% | +50.0% |
Q1 2021 | $11,000 | +22.2% | 334 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $9,000 | +200.0% | 334 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $3,000 | – | 334 | +11033.3% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 3 | -99.0% | 0.00% | -100.0% |
Q4 2019 | $2,000 | – | 298 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |